Growth Metrics

Chemours (CC) Receivables (2016 - 2025)

Chemours has reported Receivables over the past 12 years, most recently at $729.0 million for Q4 2025.

  • Quarterly results put Receivables at $729.0 million for Q4 2025, up 8.97% from a year ago — trailing twelve months through Dec 2025 was $729.0 million (up 8.97% YoY), and the annual figure for FY2025 was $729.0 million, up 8.97%.
  • Receivables for Q4 2025 was $729.0 million at Chemours, down from $997.0 million in the prior quarter.
  • Over the last five years, Receivables for CC hit a ceiling of $1.0 billion in Q2 2022 and a floor of $622.0 million in Q4 2023.
  • Median Receivables over the past 5 years was $815.5 million (2021), compared with a mean of $823.0 million.
  • Biggest five-year swings in Receivables: skyrocketed 77.49% in 2021 and later fell 23.88% in 2023.
  • Chemours' Receivables stood at $820.0 million in 2021, then fell by 11.46% to $726.0 million in 2022, then dropped by 14.33% to $622.0 million in 2023, then grew by 7.56% to $669.0 million in 2024, then grew by 8.97% to $729.0 million in 2025.
  • The last three reported values for Receivables were $729.0 million (Q4 2025), $997.0 million (Q3 2025), and $842.0 million (Q2 2025) per Business Quant data.